• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者肝切除术后总肿瘤体积作为生存预后价值的回顾性队列研究。

Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study.

作者信息

Zakaria Hazem M, Macshut Mahmoud, Gaballa Nahla K, Sherif Ahmed E, Abdel-Samea Mohammed E, Abdel-Samiee Mohamed, Marwan Ibrahim, Yassein Taha

机构信息

Department of Hepatopancreatobiliary and Liver Transplant Surgery, National Liver Institute, Menoufia University, Menoufia, Egypt.

Department of Anesthesia and Intensive Care, National Liver Institute, Menoufia University, Menoufia, Egypt.

出版信息

Ann Med Surg (Lond). 2020 Apr 7;54:47-53. doi: 10.1016/j.amsu.2020.04.001. eCollection 2020 Jun.

DOI:10.1016/j.amsu.2020.04.001
PMID:32368340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7184266/
Abstract

BACKGROUND

Total tumor volume (TTV) can provide a simplified parameter in describing the tumor burden by incorporating the size and number of tumor nodules into one continuous variable. The aim of the study was to evaluate the prognostic value of TTV in resection of hepatocellular carcinoma (HCC).

METHODS

Patients who underwent liver resection for HCC between 2012 and 2017 were retrospectively analyzed. Patients were divided into a group with TTV ≤65.5 cm³ (which nearly equal to a single tumor with a diameter of 5 cm), and another group with TTV > 65.5 cm³.

RESULTS

Two hundred and four patients were included in this study (108 patients had TTV ≤ 65.5cm3, and 96 patients had TTV > 65.5 cm³). Ninety patients (44.1%) were within Milan and 114 patients (55.9%) were beyond Milan criteria. Eighteen patients (15.8%) of beyond Milan criteria had TTV ≤ 65.5 cm³, with a median survival of 32 months which is comparable to a median survival of patients with TTV< 65.5 cm³ (38 months,  = 0.38). TTV-based Cancer of Liver Italian Program (CLIP) score gained the highest value of likelihood ratio 114.7 and the highest Concordance-index 0.73 among other prognostic scoring and staging systems. In multivariate analysis, independent risk factors for diminished survival were serum AFP level >400 ng/ml, TTV >65.5 cm³, microvascular invasion, postoperative decompensation (all values < 0.05).

CONCLUSION

TTV is a feasible prognostic measure to describe the tumor burden in patients with HCC. TTV-CLIP score may provide good prognostic value for resection of HCC than other staging systems.

摘要

背景

总肿瘤体积(TTV)通过将肿瘤结节的大小和数量整合为一个连续变量,可为描述肿瘤负荷提供一个简化参数。本研究的目的是评估TTV在肝细胞癌(HCC)切除术中的预后价值。

方法

对2012年至2017年间接受HCC肝切除术的患者进行回顾性分析。患者被分为TTV≤65.5 cm³组(几乎等同于直径为5 cm的单个肿瘤)和TTV>65.5 cm³组。

结果

本研究共纳入204例患者(108例患者TTV≤65.5 cm³,96例患者TTV>65.5 cm³)。90例患者(44.1%)符合米兰标准,114例患者(55.9%)超出米兰标准。超出米兰标准的患者中有18例(15.8%)TTV≤65.5 cm³,其中位生存期为32个月,与TTV<65.5 cm³患者的中位生存期(38个月,P=0.38)相当。在其他预后评分和分期系统中,基于TTV的意大利肝癌项目(CLIP)评分获得了最高的似然比114.7和最高的一致性指数0.73。在多变量分析中,生存时间缩短的独立危险因素为血清甲胎蛋白水平>400 ng/ml、TTV>65.5 cm³、微血管侵犯、术后失代偿(所有P值<0.05)。

结论

TTV是描述HCC患者肿瘤负荷的一种可行的预后指标。与其他分期系统相比,TTV-CLIP评分可能为HCC切除术提供良好的预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/830fd7caf3b3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/4b4c48185b3a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/a44a1516bbdf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/f6c777b23e0b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/a92c1b4a7953/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/830fd7caf3b3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/4b4c48185b3a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/a44a1516bbdf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/f6c777b23e0b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/a92c1b4a7953/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2143/7184266/830fd7caf3b3/gr5.jpg

相似文献

1
Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study.肝细胞癌患者肝切除术后总肿瘤体积作为生存预后价值的回顾性队列研究。
Ann Med Surg (Lond). 2020 Apr 7;54:47-53. doi: 10.1016/j.amsu.2020.04.001. eCollection 2020 Jun.
2
Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.肿瘤总体积可预测肝细胞癌患者肝切除术后的生存率。
Tumour Biol. 2016 Jul;37(7):9301-10. doi: 10.1007/s13277-016-4794-7. Epub 2016 Jan 15.
3
Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.肿瘤总体积是米兰标准定义的肝细胞癌肿瘤负荷的更好标志物。
World J Surg. 2013 Jun;37(6):1348-55. doi: 10.1007/s00268-013-1978-9.
4
A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.基于总肿瘤体积的肝细胞癌新预后模型:台北综合评分系统。
J Hepatol. 2010 Jul;53(1):108-17. doi: 10.1016/j.jhep.2010.01.038. Epub 2010 Mar 31.
5
Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.甲胎蛋白水平与肿瘤总体积作为肝细胞癌切除术后复发预测指标的研究。一项回顾性队列研究。
Ann Med Surg (Lond). 2020 May 4;54:109-113. doi: 10.1016/j.amsu.2020.04.014. eCollection 2020 Jun.
6
The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.术前甲胎蛋白水平与肿瘤总体积比值作为肝移植后肝细胞癌的预后因素。
Medicine (Baltimore). 2021 Jul 2;100(26):e26487. doi: 10.1097/MD.0000000000026487.
7
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.总肿瘤体积和甲胎蛋白联合用于选择肝癌肝移植候选者:前瞻性验证。
Hepatology. 2015 Jul;62(1):158-65. doi: 10.1002/hep.27787. Epub 2015 Apr 22.
8
Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer.评估总肿瘤体积和移植前甲胎蛋白水平作为肝细胞癌患者肝移植选择标准的情况。
Transplant Proc. 2013 Jun;45(5):1899-903. doi: 10.1016/j.transproceed.2012.12.010.
9
Comparison of survival rates as predicted by total tumor volume or tumor burden score in patients with hepatocellular carcinoma concurrent with fatty liver disease and hepatitis B virus.伴有脂肪性肝病和乙型肝炎病毒的肝细胞癌患者中,根据总肿瘤体积或肿瘤负荷评分预测的生存率比较。
Expert Rev Gastroenterol Hepatol. 2023 May;17(5):499-507. doi: 10.1080/17474124.2023.2196403. Epub 2023 Apr 3.
10
α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma.甲胎蛋白与肿瘤总体积比值预测肝癌术后肿瘤复发。
J Gastrointest Surg. 2013 Apr;17(4):730-8. doi: 10.1007/s11605-012-2081-5. Epub 2012 Nov 28.

引用本文的文献

1
Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number.肿瘤大小和数量之和决定的中期肝细胞癌的术后结果和复发模式。
World J Gastroenterol. 2022 Nov 28;28(44):6271-6281. doi: 10.3748/wjg.v28.i44.6271.
2
Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections.用于预测接受手术切除的肝细胞癌患者无病生存期的改良术前评分。
World J Hepatol. 2022 Sep 27;14(9):1778-1789. doi: 10.4254/wjh.v14.i9.1778.
3
Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System.

本文引用的文献

1
[Surgical treatment of hepatic tumors-liver resection and transplantation].[肝脏肿瘤的外科治疗——肝切除与肝移植]
Internist (Berl). 2020 Feb;61(2):147-157. doi: 10.1007/s00108-020-00754-8.
2
Impact of systematic segmentectomy for small hepatocellular carcinoma.系统节段切除术治疗小肝细胞癌的影响。
J Hepatobiliary Pancreat Sci. 2020 Jun;27(6):331-341. doi: 10.1002/jhbp.720. Epub 2020 Feb 27.
3
STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery.STROCSS 2019 指南:加强外科学队列研究报告。
将肝细胞癌手术切除范围扩展至超出巴塞罗那肝癌临床分期(BCLC)A期:改良BCLC分期系统的一种新应用
J Hepatocell Carcinoma. 2022 Aug 17;9:839-851. doi: 10.2147/JHC.S370212. eCollection 2022.
4
Outcomes of surgical resection of super-giant (≥15 cm) hepatocellular carcinoma: Volume does matter, if not the size.超巨大(≥15厘米)肝细胞癌手术切除的结果:重要的是体积,而非大小。
J Clin Transl Res. 2022 May 25;8(3):209-217. eCollection 2022 Jun 29.
5
A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection.一种新的基于炎症指标和肿瘤负荷评分(TBS)的模型,用于预测肝癌(HCC)肝切除术后的复发。
Sci Rep. 2022 May 23;12(1):8670. doi: 10.1038/s41598-022-12518-5.
6
Autophagy-Related Signatures as Prognostic Indicators for Hepatocellular Carcinoma.自噬相关特征作为肝细胞癌的预后指标
Front Oncol. 2022 Mar 24;12:654449. doi: 10.3389/fonc.2022.654449. eCollection 2022.
7
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures.埃及肝细胞癌的独特情况:流行病学与控制措施综述
World J Gastrointest Oncol. 2021 Dec 15;13(12):1919-1938. doi: 10.4251/wjgo.v13.i12.1919.
8
The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.年龄、国际标准化比值、白蛋白和γ-谷氨酰转肽酶(AIAG)、肿瘤大小及甲胎蛋白(AFP)分期联合作为乙型肝炎相关肝细胞癌的预后模型
Int J Gen Med. 2021 Aug 10;14:4291-4301. doi: 10.2147/IJGM.S323293. eCollection 2021.
9
Single Large Nodule (>5 cm) Prognosis in Hepatocellular Carcinoma: Kinship with Barcelona Clinic Liver Cancer (BCLC) Stage A or B?肝细胞癌中单个大结节(>5厘米)的预后:与巴塞罗那临床肝癌(BCLC)A期或B期的关系?
Med Sci Monit. 2020 Oct 16;26:e926797. doi: 10.12659/MSM.926797.
Int J Surg. 2019 Dec;72:156-165. doi: 10.1016/j.ijsu.2019.11.002. Epub 2019 Nov 6.
4
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.中国多中心研究:肝癌切除术后晚期复发的危险因素、模式和结局。
JAMA Surg. 2019 Mar 1;154(3):209-217. doi: 10.1001/jamasurg.2018.4334.
5
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.血清甲胎蛋白总肿瘤体积比作为肝癌切除术后复发的预测指标。
Surgery. 2018 May;163(5):1002-1007. doi: 10.1016/j.surg.2017.10.063. Epub 2017 Dec 25.
6
Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma.肝细胞癌活体肝移植预后的预测因素
Indian J Surg. 2017 Aug;79(4):299-307. doi: 10.1007/s12262-016-1474-1. Epub 2016 Apr 7.
7
Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.肿瘤总体积可预测肝细胞癌患者肝切除术后的生存率。
Tumour Biol. 2016 Jul;37(7):9301-10. doi: 10.1007/s13277-016-4794-7. Epub 2016 Jan 15.
8
BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A.对于单个大肝细胞癌,巴塞罗那临床肝癌(BCLC)分期系统中的B期比A期更合适。
J Gastroenterol Hepatol. 2016 Feb;31(2):467-74. doi: 10.1111/jgh.13152.
9
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.总肿瘤体积和甲胎蛋白联合用于选择肝癌肝移植候选者:前瞻性验证。
Hepatology. 2015 Jul;62(1):158-65. doi: 10.1002/hep.27787. Epub 2015 Apr 22.
10
Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.肿瘤总体积是米兰标准定义的肝细胞癌肿瘤负荷的更好标志物。
World J Surg. 2013 Jun;37(6):1348-55. doi: 10.1007/s00268-013-1978-9.